Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Depression (Esketamine hydrochloride - Depression)

Records returned : 8 (on 16 Jul 2025 at 21:40:45). Return to search results for ' Depression '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off Label

Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

SPC

View the treatment summary for {padindicationname} on https://www.medicines.org.uk

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Esketamine hydrochloride

Drug:

Esketamine hydrochloride

Indication :

Depression

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Important

Subject to NICE TA854

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

NFD1

SPC

2. Isocarboxazid

Drug:

Isocarboxazid

Indication :

Depression

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Initiation and stabilisation by specialist for a minimum of 6 months before transfer of prescribing to primary care.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

SPC

3. Lithium - adults

Drug:

Lithium - adults

Indication :

Depression

Status :

Blue

Formulations :

Not Specified

Restrictions / Comments:

Important

To be initiated by a specialist.

This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the Blue information sheet and other resources that were in place prior to the launch of the joint formulary.

Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

SPC

4. Moclobemide

Drug:

Moclobemide

Indication :

Depression

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Initiation and stabilisation by specialist for a minimum of 6 months before transfer of prescribing to primary care.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

SPC

5. Phenelzine sulfate

Drug:

Phenelzine sulfate

Indication :

Depression

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Initiation and stabilisation by specialist for a minimum of 6 months before transfer of prescribing to primary care.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

SPC

6. Quetiapine

Drug:

Quetiapine

Indication :

Depression

Status :

Blue

Formulations :

Immediate release tablets

Restrictions / Comments:

Important

Preferred

Adjunctive treatment of major depression.

Initiation and stabilisation by a SABP specialist for a minimum of 3 months before any request for transfer of prescribing responsibility.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

8. Quetiapine

Drug:

Quetiapine

Indication :

Depression

Status :

Red

Formulations :

Modified release tablets

Restrictions / Comments:

Important

Adjunctive treatment of major depression.

Modified release tablets are reserved for use when immediate release tablets are not suitable.

Modified release quetiapine MAY be continued in Primary Care (after a 3-month period of stabilisation by SABP) where the use of immediate release tablets would risk destabilising the patient.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :